Covidien Announces Nominees to Board of Directors for Mallinckrodt Pharmaceutical Business

[Business Wire] – DUBLIN–(BUSINESSWIRE)– Covidien (NYSE:COV) today announced nominees to the future board of directors of Mallinckrodt plc as Mallinckrodt prepares to become a separate, independently traded company in … more

View todays social media effects on COV

View the latest stocks trending across Twitter. Click to view dashboard

See who Covidien is hiring next, click here to view